Elinest Kit
Product Images NDC 16714-365

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Elinest (NDC 16714-365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Chemical structure diagrams of the active ingredients Norgestrel and Ethinyl Estradiol, showing detailed molecular formulas and molecular weights for each compound.*

FDA Label Image

2 (Image 02)

A boxed warning text panel advising that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, particularly in women over 35 years old and those who smoke 15 or more cigarettes per day. It strongly advises women using oral contraceptives not to smoke.*

FDA Label Image

3 (Image 03)

A bar graph titled 'Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use,' showing mortality rate data across four age groups (15-24, 25-34, 35-44, and 45+). The graph compares four categories: Ever-Users (Nonsmokers), Controls (Nonsmokers), Ever-Users (Smokers), and Controls (Smokers), with mortality rates increasing notably with age and being highest among Controls who smoke.*

FDA Label Image

4 (Image 04)

A warning text panel indicating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, especially in women over 35 years old and heavy smokers (15 or more cigarettes per day). It strongly advises women who use oral contraceptives not to smoke.*

FDA Label Image

5 (Image 05)

Illustration of an Elinest pill blister card showing active pills in pale pink and reminder pills in white. The card is organized by weeks and days of the week, with instructions for use, storage, and a note about monthly self-breast exams. The Elinest logo and product details appear alongside the pill layout.*

FDA Label Image

6 (Image 06)

Illustration showing a hand placing a day label strip labeled with days of the week (MON, TUE, WED, THU, FRI, SAT, SUN) onto a blister pack for Elinest tablets. The diagram includes instructions to pick the correct day label and affix it to the blister pack for daily dose tracking.*

FDA Label Image

7 (Image 07)

A warning panel about the increased risk of serious cardiovascular side effects from oral contraceptive use associated with cigarette smoking. It advises that the risk increases with age and heavy smoking (15 or more cigarettes per day), especially in women over 35 years old, and strongly advises women using oral contraceptives not to smoke.*

FDA Label Image

8 (Image 08)

Label panel for Elinest kit, a human prescription drug containing norgestrel and ethinyl estradiol. The label states it is manufactured for Northstar Rx LLC, Memphis, TN, and by Novast Laboratories Ltd., Nantong, China, and includes a toll-free contact number.*

FDA Label Image

9 (Image 09)

Packaging label for Elinest, a kit containing Norgestrel and Ethinyl Estradiol tablets USP, with strengths of 0.3 mg and 0.03 mg respectively. The label shows a 6 blister pack kit with 28-day regimen, produced by Northstar Rx LLC. The design includes pink text and a flower graphic, with dosage and regulatory information noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.